|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3707 USD | +3.00% |
|
-5.26% | -53.14% |
Company Valuation: Trinity Biotech plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 79.64 | 29.89 | 37.73 | 16.39 | 15.34 | 14.69 |
| Change | - | -62.47% | 26.22% | -56.55% | -6.42% | -4.25% |
| Enterprise Value (EV) 1 | 156.6 | 103.2 | 103.3 | 80.13 | 110.9 | 147.5 |
| Change | - | -34.14% | 0.18% | -22.47% | 38.45% | 32.99% |
| P/E | -12.5x | 38.2x | -0.81x | -0.68x | -0.48x | -0.39x |
| PBR | -35.9x | -93.7x | -17.3x | -0.69x | -0.45x | -0.21x |
| PEG | - | -0x | 0x | 0x | 0x | -0.04x |
| Capitalization / Revenue | 0.78x | 0.32x | 0.5x | 0.29x | 0.25x | 0.34x |
| EV / Revenue | 1.54x | 1.11x | 1.38x | 1.41x | 1.8x | 3.37x |
| EV / EBITDA | 7.62x | 9.78x | -10.9x | -5.6x | -8.51x | -17.9x |
| EV / EBIT | 8.49x | 11.6x | -9.46x | -4.98x | -8.1x | -15.5x |
| EV / FCF | 25x | -133x | -12.2x | -6.24x | -15.8x | -13.2x |
| FCF Yield | 4.01% | -0.75% | -8.2% | -16% | -6.34% | -7.59% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.528 | 0.1871 | -6.078 | -3.138 | -1.832 | -2.012 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 102 | 92.96 | 74.78 | 56.83 | 61.56 | 43.78 |
| EBITDA 1 | 20.56 | 10.55 | -9.521 | -14.3 | -13.03 | -8.243 |
| EBIT 1 | 18.45 | 8.901 | -10.92 | -16.08 | -13.7 | -9.546 |
| Net income 1 | -6.388 | 0.875 | -41.01 | -24.02 | -31.79 | -37.38 |
| Net Debt 1 | 77.01 | 73.28 | 65.62 | 63.74 | 95.6 | 132.8 |
| Reference price 2 | 19.0500 | 7.1500 | 4.9500 | 2.1450 | 0.8802 | 0.7910 |
| Nbr of stocks (in thousands) | 4,180 | 4,180 | 7,622 | 7,642 | 17,426 | 18,566 |
| Announcement Date | 30/04/21 | 02/05/22 | 16/05/23 | 30/04/24 | 16/05/25 | 30/04/26 |
1USD in Million2USD
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 7.51M | ||
| -53.48x | 16.1x | -117.84x | -.--% | 20.55B | ||
| 17.47x | 1.98x | 8.26x | 1.48% | 9.81B | ||
| 23.75x | 4.49x | 12.65x | - | 6.84B | ||
| -54.83x | 8.42x | -71.65x | -.--% | 5.65B | ||
| 19.33x | 6.63x | 14.99x | 2.98% | 5.22B | ||
| 167.7x | 4.2x | 27.48x | -.--% | 4.66B | ||
| 20.33x | 3.57x | 11.09x | 1.87% | 4.23B | ||
| 16.62x | - | - | 3.86% | 2.79B | ||
| Average | 19.61x | 6.48x | -16.43x | 1.45% | 6.64B | |
| Weighted average by Cap. | -1.01x | 8.74x | -42.23x | 0.92% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- TRIB Stock
- Valuation Trinity Biotech plc
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















